The optimal therapy for lupus nephritis remains controversial. Join your colleagues for this complimentary CME program, which investigates the pathology of this disease and examines the role of new and emerging forms of treatment.

Lupus Nephritis Update:
The Evolving Role of Biologic Therapies
CME-accredited activity

Faculty

Michael P. Madaio, MD - Program Chair
Temple University School of Medicine
Philadelphia, Pennsylvania

James E. Balow, MD
National Institutes of Health
Bethesda, Maryland

Gabriel Contreras, MD, MPH
University of Miami
Miami, Florida

Melvin M. Schwartz, MD
Rush University Medical Center
Chicago, Illinois

Vibeke Strand, MD, FACP, FACR
Stanford University School of Medicine
Portola Valley, California

Medium or Combination of Media Used

Streaming video with slides.

System Requirements

For a successful viewing experience, the following hardware and software are required:

- Broadband cable, DSL or high-speed Internet connection
- 16-bit color display with resolution 1024 x 768 pixels or greater
- Macromedia Flash Player 7 or greater (download here)
- Sound card and speakers

To test your system for compatibility, visit http://web.stream57.com/conntest

Method of Physician Participation

Study the educational content. Complete the posttest; 80% correct required for full credit on first submission.

A continuing education program based on the proceedings of an official symposium held at the American Society of Nephrology Renal Week on November 4, 2007, in San Francisco, California.

Credit eligible through: June 30, 2009.